HRP20140254T1 - CRYSTALLINE FORM OF 1- (ß-D-GLUCOPYRANOSYL) -4 -METHYL- 3- [5- (4 -FLUOROPHENYL) -2-THIENYLMETHYL]BENZENE HEMIHYDRATE - Google Patents

CRYSTALLINE FORM OF 1- (ß-D-GLUCOPYRANOSYL) -4 -METHYL- 3- [5- (4 -FLUOROPHENYL) -2-THIENYLMETHYL]BENZENE HEMIHYDRATE

Info

Publication number
HRP20140254T1
HRP20140254T1 HRP20140254TT HRP20140254T HRP20140254T1 HR P20140254 T1 HRP20140254 T1 HR P20140254T1 HR P20140254T T HRP20140254T T HR P20140254TT HR P20140254 T HRP20140254 T HR P20140254T HR P20140254 T1 HRP20140254 T1 HR P20140254T1
Authority
HR
Croatia
Prior art keywords
thienylmethyl
glucopyranosyl
fluorophenyl
methyl
crystalline form
Prior art date
Application number
HRP20140254TT
Other languages
Croatian (hr)
Inventor
Sumihiro Nomura
Eiji Kawanishi
Original Assignee
Mitsubishi Tanabe Pharma Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2007/073729 external-priority patent/WO2008069327A1/en
Application filed by Mitsubishi Tanabe Pharma Corporation filed Critical Mitsubishi Tanabe Pharma Corporation
Publication of HRP20140254T1 publication Critical patent/HRP20140254T1/en
Publication of HRP20140254T4 publication Critical patent/HRP20140254T4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals
HRP20140254TT 2006-12-04 2014-03-18 CRYSTALLINE FORM OF 1- (ß-D-GLUCOPYRANOSYL) -4 -METHYL- 3- [5- (4 -FLUOROPHENYL) -2-THIENYLMETHYL]BENZENE HEMIHYDRATE HRP20140254T4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86842606P 2006-12-04 2006-12-04
JP2006327019 2006-12-04
PCT/JP2007/073729 WO2008069327A1 (en) 2006-12-04 2007-12-03 CRYSTALLINE FORM OF 1- (β-D-GLUCOPYRANOSYL) -4 -METHYL- 3- [5- (4 -FLUOROPHENYL) -2-THIENYLMETHYL] BENZENE HEMIHYDRATE
EP07850306.7A EP2102224B2 (en) 2006-12-04 2007-12-03 CRYSTALLINE FORM OF 1- (ß-D-GLUCOPYRANOSYL) -4 -METHYL- 3- [5- (4 -FLUOROPHENYL) -2-THIENYLMETHYL]BENZENE HEMIHYDRATE

Publications (2)

Publication Number Publication Date
HRP20140254T1 true HRP20140254T1 (en) 2014-04-25
HRP20140254T4 HRP20140254T4 (en) 2021-10-29

Family

ID=50486662

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20140254TT HRP20140254T4 (en) 2006-12-04 2014-03-18 CRYSTALLINE FORM OF 1- (ß-D-GLUCOPYRANOSYL) -4 -METHYL- 3- [5- (4 -FLUOROPHENYL) -2-THIENYLMETHYL]BENZENE HEMIHYDRATE

Country Status (3)

Country Link
HR (1) HRP20140254T4 (en)
NI (1) NI200900113A (en)
UA (1) UA93135C2 (en)

Also Published As

Publication number Publication date
UA93135C2 (en) 2011-01-10
HRP20140254T4 (en) 2021-10-29
NI200900113A (en) 2010-11-29

Similar Documents

Publication Publication Date Title
ZA200903941B (en) Crystalline form of 1- (Beta-D-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene hemihydrate
IL204145A (en) Processes for the preparation of sglt inhibitors, crystalline forms of 1-(β-d-glucopyranosyl)-4-chloro-3-[5-(6-fluoro-3-pyridyl)-2-thienylmethyl]benzene, pharmaceutical compositions comprising them and uses thereof
TWI370818B (en) Cocrystal of c-glycoside derivative and l-proline
HRP20130561T1 (en) CRYSTALLISATION PROCESS FOR 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE
EP1990326A4 (en) Piezoelectric ceramic composition
ZA200903971B (en) Crystalline modification of fipronil
IL198264A0 (en) Crystalline modification of fipronil
IL198262A0 (en) Crystalline modification of fipronil
EP2001489A4 (en) Pharmaceutical compositions for promoting wound healing
ZA200903972B (en) Crystalline modification of fipronil
IL195061A0 (en) Crystalline forms of atorvastatin
EP1986997A4 (en) New crystalline form of atorvastatin hemi-calcium
HRP20140254T1 (en) CRYSTALLINE FORM OF 1- (ß-D-GLUCOPYRANOSYL) -4 -METHYL- 3- [5- (4 -FLUOROPHENYL) -2-THIENYLMETHYL]BENZENE HEMIHYDRATE
IL195092A0 (en) Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
EP2073855A4 (en) Injectable resorbable ceramic compositions
GB0619891D0 (en) Pharmaceutical composition of risedronate
GB0613566D0 (en) Crystalline sodium atorvastatin
PL383821A1 (en) New polymorphous form of crystalline half-calcium atorvastatin salt
AU2006907238A0 (en) Non-distribution of network interfaces & structures
AU2006903671A0 (en) Cement composition
GB0613567D0 (en) Crystalline sodium atorvastatin
AU2006905200A0 (en) Concrete composition